RituximabLack of efficacy in off-label use: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1946卷 / 1期

关键词：

D O I：

10.1007/s40278-023-35093-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：492 / 492

相关论文

共 50 条

[21] ItraconazoleLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1911 (1) : 254 - 254
[22] NifedipineLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1918 (1) : 386 - 386
[23] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1866 (1) : 47 - 47
[24] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1951 (1) : 49 - 49
[25] IdebenoneLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2022, 1929 (1) : 335 - 335
[26] LetermovirLack of efficacy and off-label use : case report
[J]. Reactions Weekly, 2024, 2019 (1) : 242 - 242
[27] FavipiravirLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1980 (1) : 175 - 175
[28] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1883 (1) : 45 - 45
[29] AntineoplasticsLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2021, 1857 (1) : 44 - 44
[30] NivolumabLack of efficacy and off-label use: case report
[J]. Reactions Weekly, 2023, 1945 (1) : 417 - 417

← 1 2 3 4 5 →